Short Interest in BioSyent Inc. (OTCMKTS:BIOYF) Declines By 69.2%

BioSyent Inc. (OTCMKTS:BIOYF) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 400 shares, a decrease of 69.2% from the October 31st total of 1,300 shares. Based on an average daily volume of 4,000 shares, the short-interest ratio is presently 0.1 days.

BioSyent Stock Performance

BIOYF remained flat at $8.05 during mid-day trading on Friday. 100 shares of the company’s stock were exchanged, compared to its average volume of 2,237. The stock’s 50-day moving average is $8.03 and its two-hundred day moving average is $7.54. BioSyent has a 1-year low of $5.93 and a 1-year high of $8.90.

BioSyent Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be given a dividend of $0.0322 per share. This represents a yield of 1.6%. The ex-dividend date is Friday, November 29th.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.